Dow Up 1.30% Nasdaq Up 0.37%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
12.06 0.13(1.09%) Oct 30, 4:00PM EDT
Prev Close:11.93
Open:11.79
Bid:12.10 x 800
Ask:12.22 x 500
1y Target Est:17.73
Beta:3.81
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:11.70 - 12.22
52wk Range:4.55 - 14.62
Volume:528,275
Avg Vol (3m):1,408,410
Market Cap:865.38M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXUp 1.09%865.38M
GSK108.52B
RHHBY252.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-2.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback